Leukemia Montesinos, P, Roboz, G J, Bulabois, C E, Subklewe, M, Platzbecker, U, Ofran, Y, Papayannidis, C, Wierzbowska, A, Shin, H J, Doronin, V, Deneberg, S, Yeh, S P, Ozcan, M A, Knapper, S, Cortes, J, Pollyea, D A, Ossenkoppele, G, Giralt, S, Döhner, H, Heuser, M, Xiu, L, Singh, I, Huang, F, Larsen, J S & Wei, A H 2021, ' Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy : results from a multicenter, randomized, phase 2/3 study ', Leukemia, vol. 35, no. 1, pp. 62-74 . https://doi.org/10.1038/s41375-020-0773-5 r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname Leukemia, 35(1), 62-74. Nature Publishing Group